user

SYNERGISTIC EFFECTS OF BAY-604552 AND VARDENAFIL ON RELAXATION OF CORPUS CAVERNOSUM TISSUE OF PATIENTS WITH ERECTILE DYSFUNCTION AND CLINICAL PHOSPHODIESTERASE 5-INHIBITOR FAILURE

被引：0
|
作者：
Albersen, M.
Linsen, L. [1 ]
Tinel, H. [2 ]
Sandner, P. [2 ]
Van Renterghem, K.
机构：
[1] Jessa Hosp, Biobank Limburg, Hasselt, Belgium
[2] Bayer HealthCare, Global Drug Discovery, Wuppertal, Germany
来源：
JOURNAL OF SEXUAL MEDICINE | 2012年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
110
引用
收藏
页码：221 / 221
页数：1
相关论文
共 28 条
  • [1] SYNERGISTIC EFFECTS OF BAY-604552 AND VARDENAFIL ON RELAXATION OF CORPUS CAVERNOSUM TISSUE OF PATIENTS WITH ERECTILE DYSFUNCTION AND CLINICAL PDE5-INHIBITOR FAILURE
    Albersen, M.
    Linsen, L.
    Tinel, H.
    Sandner, P.
    Van Renterghem, K.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 346 - 346
  • [2] Synergistic Effects of BAY 60-4552 and Vardenafil on Relaxation of Corpus Cavernosum Tissue of Patients with Erectile Dysfunction and Clinical Phosphodiesterase Type 5 Inhibitor Failure
    Albersen, Maarten
    Linsen, Loes
    Tinel, Hanna
    Sandner, Peter
    Van Renterghem, Koenraad
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 (05): : 1268 - 1277
  • [3] SYNERGISTIC EFFECTS OF Y-27632 AND VARDENAFIL ON RELAXATION OF CORPUS CAVERNOSUM TISSUE OF PATIENTS WITH ERECTILE DYSFUNCTION AND CLINICAL PHOSPHODIESTERASE TYPE 5 INHIBITOR FAILURE
    Uvin, P.
    Albersen, M.
    Bollen, I
    Falter, M.
    Linsen, L.
    Tinel, I. L.
    Sandner, P.
    Bivalacqua, T.
    De Ridder, D.
    Van Der Aa, F.
    Brone, B.
    Van Renterghent, K.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 211 - 211
  • [4] Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure
    Uvin, Pieter
    Albersen, Maarten
    Bollen, Ine
    Falter, Maarten
    Weyne, Emmanuel
    Linsen, Loes
    Tinel, Hanna
    Sandner, Peter
    Bivalacqua, Trinity J.
    De Ridder, Dirk J. M. K.
    Van der Aa, Frank
    Brone, Bert
    Van Renterghem, Koenraad
    BJU INTERNATIONAL, 2017, 119 (02) : 325 - 332
  • [5] Testosterone Induces Relaxation of Human Corpus Cavernosum Tissue of Patients With Erectile Dysfunction
    Van den Broeck, Thomas
    Soebadi, Mohammad Ayodhia
    Falter, Annelies
    Raets, Lore
    Duponselle, Jolien
    Lootsma, Joline
    Heintz, Alexander
    Philtjens, Uchelly
    Hofkens, Lien
    Gonzalez-Viedma, Arantxa
    Driesen, Karel
    Sandner, Peter
    Albersen, Maarten
    Brone, Bert
    Van Renterghem, Koenraad
    SEXUAL MEDICINE, 2020, 8 (01): : 114 - 119
  • [6] TESTOSTERONE INDUCES RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE OF PATIENTS WITH ERECTILE DYSFUNCTION
    Van den Broeck, T.
    Soebadi, Y.
    Falter, A.
    Raets, L.
    Duponselle, J.
    Lootsma, J.
    Heintz, A.
    Philtjens, U.
    Hofkens, L.
    Viedma, A. G.
    Driesen, K.
    Sandner, P.
    Albersen, M.
    Brone, B.
    Van Renterghem, K.
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S131 - S131
  • [7] Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in type 1 diabetic patients with erectile dysfunction
    Ziegler, D
    Merfort, F
    Van Ahlen, H
    Reblin, T
    Neureither, M
    DIABETES, 2005, 54 : A127 - A127
  • [8] Predictors of Phosphodiesterase Type 5 Inhibitor Treatment Failure in Patients Diagnosed With Erectile Dysfunction
    Albarakati, Muath
    El-Tholoth, Hossam S.
    Alzahrani, Abdulaziz
    Alghamdi, Omar S.
    Alquliti, Abdulrahman
    Alnuami, Musa
    Althobity, Abdalmagid
    Almardawi, Abdulmalik
    Bedaiwi, Khaled
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [9] The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial
    Porst, H
    Rosen, R
    Padma-Nathan, H
    Goldstein, I
    Giuliano, F
    Ulbrich, E
    Bandel, T
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2001, 13 (04) : 192 - 199
  • [10] The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial
    H Porst
    R Rosen
    H Padma-Nathan
    I Goldstein
    F Giuliano
    E Ulbrich
    International Journal of Impotence Research, 2001, 13 : 192 - 199
123